Bone mineral density in breast cancer patients with positive estrogen receptor tumor status

Maturitas

Volumn 57, Issue 3, 2007, Pages 221-225

  Douchi, Tsutomu ^a   Yonehara, Yukie ^a   Kosha, Shoichiro ^b   Iwamoto, Ichiro ^a   Rai, Yoshiaki ^b   Sagara, Yoshiatsu ^b   Umekita, Yoshihisa ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Sagara Clinic 21   (Japan)

Author keywords

Bone mineral density; Estrogen receptor tumor status; Postmenopausal breast cancer

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; BONE DENSITY; BONE MINERAL; BREAST CANCER; CANCER PATIENT; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; POSTMENOPAUSE;

BODY MASS INDEX; BONE DENSITY; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DENSITOMETRY, X-RAY; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS, HORMONE-DEPENDENT; POSTMENOPAUSE; RECEPTORS, ESTROGEN;

EID: 34249986092     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2006.11.012     Document Type: Article

References (29)

1. Douchi T., Yamamoto S., Nakamura S., Oki T., Maruta K., and Nagata Y. Bone mineral density in postmenopausal women with endometrial cancer. Maturitas 31 (1999) 165-170
2. Nguyen T.V., Center J.R., and Eisman J.A. Association between breast cancer and bone mineral density: the Dubbo Osteoporosis Epidemiology Study. Maturitas 31 (2000) 27-34
3. Cauley J.A., Lucas F.L., Kuller L.H., Vogt M.T., Browner W.S., and Cummings S.R. Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group. JAMA 276 (1996) 1404-1408
4. Zhang Y., Kiel D.P., Kreger B.E., et al. Bone mass and the risk of breast cancer among postmenopausal women. N Engl J Med 336 (1997) 611-617
5. Van der Klift M., de Laet C.E., Coebergh J.W., Hofman A., and Pols H.A. Rotterdam Study. Bone 32 (2003) 211-216
6. Zmuda J.M., Cauley J.A., Ljung B.M., et al. Bone mass and breast cancer risk in older women: differences by stage at diagnosis. J Natl Cancer Inst 93 (2001) 930-936
7. Crabdall C., Petersen L., Ganz P.A., and Greendale G.A. Bone mineral density and adjuvant therapy in breast cancer survivor. Breast Cancer Res Treat 88 (2004) 257-261
8. Olsson H., and Hagglund G. Reduced cancer morbidity and mortality in a prospective cohort of women with distal forearm fractures. Am J Epidemiol 136 (1992) 422-427
9. Douchi T., Tsuji T., Tokuhisa T., et al. Relation of estrogen receptor in endometrial cancer specimens to bone mineral density. Acta Obstet Gynecol Scand 79 (2000) 1011-1014
10. Pertschuk L.P., Feldman J.G., Kim Y.D., et al. Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Spγ frozen sections or cytosol-based ligand-binding assays. Cancer 77 (1996) 2514-2519
11. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
12. Reeves G.K., Beral V., Green J., Gathani T., Bull D., and for the Million Women Study Collaborators. Hormone therapy for menopause and breast cancer risk by histological type: a cohort study and meta-analysis. Lancet Oncol 7 (2006) 910-918
13. Golditz G.A., Hankinson S.E., Hunter D.J., et al. The use of estrogen and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 332 (1995) 1589-1593
14. Laufer L.R., Davidson B.J., Ross R.K., Lagasse L.D., Siiteri P.K., and Judd H.L. Physical characteristics and sex hormone levels in patients with osteoporotic hip fractures or endometrial cancer. Am J Obstet Gynecol 145 (1983) 585-590
15. Mazess R.B., Barden J.P., Bisek J.P., and Hanson J. Dual-energy X-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr 51 (1990) 1106-1112
16. Johnson J., and Dawson-Hughes B. Precision and stability of dual-energy X-ray absorptiometry measurements. Calcif Tissue 49 (1991) 174-178
17. MacMahon B. Risk factors for endometrial cancer. Gynecol Oncol 2 (1974) 122-129
18. Peterson E.P. Endometrial cancer in young women. Obstet Gynecol 31 (1968) 702-707
19. Newcomb P.A., Trentham-Dietz A., Egan K.M., et al. Fracture history and risk of breast and endometrial cancer. Am J Epidemiol 153 (2001) 1071-1078
20. Buist D.S., LaCroix A.Z., Barlow W.E., et al. Bone mineral density and endogenous hormones and risk of breast cancer in postmenopausal women (United States). Cancer Causes Control 12 (2001) 213-222
21. Nelson D.A., Darga L.L., Simon M.S., and Severson R.K. Radial bone density and breast cancer risk in white and African-American women. Osteoporosis Int 15 (2004) 535-540
22. Zmuda J.M., Cauley J.A., Ljung B.M., Bauer D.C., Cummings S.R., and Kuller L.H. Bone mass and breast cancer risk in older women: differences by stage at diagnosis. J Natl Cancer Inst 93 (2001) 930-936
23. Judd H.L., Shamonki I.M., Frumar A.M., and Lagasse L.D. Origin of serum estradiol in postmenopausal women. Obstet Gynecol 59 (1981) 680-686
24. Nimrod A., and Ryan K.J. Aromatization of androgens by human abdominal and breast fat tissue. J Clin Endocrinol Metab 40 (1975) 367-372
25. Ley C.J., Lees B., and Stevenson J.C. Sex- and menopause-associated changes in body-fat distribution. Am J Clin Nutr 55 (1992) 950-954
26. Kirschner M.A., and Samojlik E. Sex hormone metabolism in upper and lower body obesity. Int J Obes 15 (1991) 101-108
27. Connolly B.S., Barnett C., Vogt K.N., Li T., Stone J., and Boyd N.F. A meta-analysis of published literature on waist-to-hip ratio and risk of breast cancer. Nutr Cancer 44 (2002) 127-138
28. Den Tonkelaar I., Seidell J.C., and Collette H.J. Body fat distribution in relation to breast cancer in women participating in the DOM-project. Breast Cancer Res Treat 34 (1995) 55-61
29. Morimoto L.M., White E., Chn Z., et al. Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control 13 (2002) 741-751